2. Antibody-drug Conjugate/ADC Related
  3. ADC Linker Drug-Linker Conjugates for ADC
  4. Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT

DBCO-PEG2-C2-acid is an ADC Linker. DBCO-PEG2-C2-acid can be used to synthesize Antibody-Drug Conjugates (ADCs).

For research use only. We do not sell to patients.

Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT Chemical Structure

Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT Chemical Structure

CAS No. : 2396667-62-0

Size Price Stock
1 mg USD 320 Ask For Quote & Lead Time
5 mg USD 800 Ask For Quote & Lead Time
10 mg USD 1300 Ask For Quote & Lead Time

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT Related Antibodies

Top Publications Citing Use of Products

View All ADC Linker Isoform Specific Products:

View All Isoforms
Cleavable Linker Non-cleavable Linker Acid Cleavable Linker Disulfide Cleavable Linker Protease Cleavable Linker Glycosidase Cleavable Linker Phosphatase Cleavable Linker

View All Drug-Linker Conjugates for ADC Isoform Specific Products:

View All Isoforms
Auristatin Camptothecins Daunorubicins/Doxorubicins Duocarmycins Maytansinoids Pyrrolobenzodiazepines Traditional Cytotoxic Agents

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

DBCO-PEG2-C2-acid is an ADC Linker. DBCO-PEG2-C2-acid can be used to synthesize Antibody-Drug Conjugates (ADCs)[1].

Molecular Weight

984.87

Formula

C46H44N6O19
CAS No.
Appearance

Solid

Color

Light yellow to yellow

SMILES

O=C(C=CC1=O)N1CCC(NCCC(NC(C=C2COC(NCC3=C4C(C(N5C4)=CC([C@](O)(C(OC6)=O)CC)=C6C5=O)=NC7=CC(OCO8)=C8C=C73)=O)=C(C=C2)O[C@@H]9O[C@@H]([C@H]([C@@H]([C@H]9O)O)O)C(O)=O)=O)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

-20°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (101.54 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.0154 mL 5.0768 mL 10.1536 mL
5 mM 0.2031 mL 1.0154 mL 2.0307 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.0154 mL 5.0768 mL 10.1536 mL 25.3841 mL
5 mM 0.2031 mL 1.0154 mL 2.0307 mL 5.0768 mL
10 mM 0.1015 mL 0.5077 mL 1.0154 mL 2.5384 mL
15 mM 0.0677 mL 0.3385 mL 0.6769 mL 1.6923 mL
20 mM 0.0508 mL 0.2538 mL 0.5077 mL 1.2692 mL
25 mM 0.0406 mL 0.2031 mL 0.4061 mL 1.0154 mL
30 mM 0.0338 mL 0.1692 mL 0.3385 mL 0.8461 mL
40 mM 0.0254 mL 0.1269 mL 0.2538 mL 0.6346 mL
50 mM 0.0203 mL 0.1015 mL 0.2031 mL 0.5077 mL
60 mM 0.0169 mL 0.0846 mL 0.1692 mL 0.4231 mL
80 mM 0.0127 mL 0.0635 mL 0.1269 mL 0.3173 mL
100 mM 0.0102 mL 0.0508 mL 0.1015 mL 0.2538 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT2396667-62-0ADC LinkerDrug-Linker Conjugates for ADCAntibody-drug conjugates linkerInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT
Cat. No.:
HY-164367
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.